Get the Stockscreener App
0.43
19.66%
-0.1052
Estrella Immunopharma Inc Stock (ESLA) Forecast
The Estrella Immunopharma Inc (ESLA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.4201, representing a -2.31% decrease from the current price of $0.43. The highest analyst price target is $0.4018, and the lowest is $0.4383.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ESLA Price Target
Average 0.8605
(+100.11% Upside)
Is Estrella Immunopharma Inc (ESLA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 44.97 | Neutral |
| STOCH(9,6) | 24.90 | Neutral |
| STOCHRSI(14) | 72.07 | Neutral |
| MACD(12,26) | -0.0543 | Buy |
| ADX(14) | 49.15 | Buy |
| William %R | -75.68 | Neutral |
| CCI(14) | 24.85 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.4042
Buy
|
0.4177
Buy
|
| MA20 |
0.4377
Sell
|
0.4526
Sell
|
| MA50 |
0.5874
Sell
|
0.5721
Sell
|
| MA100 |
0.7595
Sell
|
0.7388
Sell
|
| MA200 |
1.0169
Sell
|
0.9373
Sell
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, ESLA could be considered a Moderate Sell, with 17 technical analysis indicators signaling 4 Buy signals, 8 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on ESLA, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 44.97 indicates that ESLA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 24.9 indicates that ESLA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 72.07 indicates that ESLA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 49.15 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 24.85 indicates that ESLA is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ESLA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Estrella Immunopharma Inc financial reports and earnings history, Estrella Immunopharma Inc (ESLA) stock could reach $0.3968 by 2030, $1.1369 by 2040 and $3.6875 by 2050. See the projected annual prices until 2050 of the Estrella Immunopharma Inc stock below:
- Estrella Immunopharma Inc (ESLA) is expected to reach an average price of $2.6825 in 2035, with a high prediction of $2.667 and a low estimate of $2.8773. This indicates an $523.84% rise from the last recorded price of $0.43.
- Estrella Immunopharma Inc (ESLA) stock is projected to chart a bullish course in 2040, with an average price target of $1.1092, representing an $157.95% surge from its current level. The forecast ranges from a conservative $1.1896 to a sky-high $1.1369.
- Our analysts predict Estrella Immunopharma Inc (ESLA) to jump 1,647% by 2045, soaring from $7.6629 to an average price of $7.5129, potentially reaching $7.6965. While $7.6629 is the low estimate, the potential upside is significant.
- Estrella Immunopharma Inc (ESLA) stock is expected to climb by 2050, reaching an average of $3.8203, a $788.44% jump from its current level. However, a wide range of estimates exists, with high and low targets of $3.6875 and $3.8453, respectively, highlighting the market's uncertainty.
Estrella Immunopharma Inc Stock (ESLA) Year by Year Forecast
Estrella Immunopharma Inc Stock (ESLA) Price Forecast for 2026
The predicted value for Estrella Immunopharma Inc (ESLA) in 2026 is set at an average of $1.1975. Estimates vary from a peak of $2.10 to a trough of $0.295, indicating an +178.49% surge from the present price of $0.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $0.6339 | $0.4383 | $0.4018 | +47.41% |
| December, 2026 | $0.4391 | $0.4391 | $0.5464 | +2.12% |
Estrella Immunopharma Inc Stock (ESLA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Estrella Immunopharma Inc (ESLA) is $0.8605, with a high forecast of $1.6771 and a low forecast of $0.0438. This indicates an +100.11% increase from the last price of $0.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.7428 | $0.6709 | $0.5828 | +72.74% |
| February, 2027 | $0.5963 | $0.7164 | $0.6337 | +38.68% |
| March, 2027 | $0.761 | $0.6782 | $0.5976 | +76.97% |
| April, 2027 | $0.6246 | $0.7328 | $0.6628 | +45.26% |
| May, 2027 | $0.6192 | $0.6365 | $0.4884 | +44.00% |
| June, 2027 | $0.5728 | $0.6528 | $0.591 | +33.22% |
| July, 2027 | $0.7175 | $0.6949 | $0.6065 | +66.86% |
| August, 2027 | $0.151 | $0.421 | $0.6293 | -64.87% |
| September, 2027 | $0.0847 | $0.0438 | $1.6771 | -80.30% |
| October, 2027 | $0.2383 | $0.1965 | $0.1983 | -44.57% |
| November, 2027 | $0.2929 | $0.4529 | $0.3411 | -31.88% |
| December, 2027 | $0.5166 | $0.4438 | $0.5266 | +20.13% |
Estrella Immunopharma Inc Stock (ESLA) Price Forecast for 2028
In 2028, Estrella Immunopharma Inc (ESLA) is projected to reach an average price of $0.2803, with a high projection of $0.5458 and a low estimate of $0.0148. This indicates an -34.81% fall from the last price of $0.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.4611 | $0.561 | $0.5458 | +7.24% |
| February, 2028 | $0.1748 | $0.2439 | $0.182 | -59.36% |
| March, 2028 | $0.1084 | $0.2441 | $0.0484 | -74.79% |
| April, 2028 | $0.1421 | $0.2121 | $0.0911 | -66.96% |
| May, 2028 | $0.2966 | $0.0338 | $0.5361 | -31.02% |
| June, 2028 | $0.3003 | $0.2624 | $0.2094 | -30.17% |
| July, 2028 | $0.0252 | $0.0148 | $0.2123 | -94.15% |
| August, 2028 | $0.0889 | $0.1585 | $0.0943 | -79.33% |
| September, 2028 | $0.1811 | $0.1438 | $0.0906 | -57.88% |
| October, 2028 | $0.1067 | $0.1849 | $0.1339 | -75.19% |
| November, 2028 | $0.0703 | $0.1573 | $0.1285 | -83.64% |
| December, 2028 | $0.106 | $0.0265 | $0.156 | -75.35% |
Estrella Immunopharma Inc Stock (ESLA) Price Forecast for 2029
The 2029 price forecast for Estrella Immunopharma Inc Stock (ESLA) is $1.1965 on average, with a high prediction of $2.2878 and a low estimate of $0.1051. This represents an +178.24% increase from the previous price of $0.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.3915 | $0.1051 | $0.6224 | -8.96% |
| February, 2029 | $2.0678 | $0.4292 | $2.2878 | +380.88% |
| March, 2029 | $1.1642 | $0.656 | $2.1469 | +170.73% |
| April, 2029 | $0.6096 | $0.5996 | $1.3432 | +41.77% |
| May, 2029 | $0.3759 | $0.1471 | $0.7687 | -12.57% |
| June, 2029 | $0.5123 | $0.235 | $0.7941 | +19.14% |
| July, 2029 | $0.3977 | $0.2986 | $0.6828 | -7.50% |
| August, 2029 | $0.9541 | $0.3568 | $1.4559 | +121.88% |
| September, 2029 | $0.5204 | $0.5204 | $1.1923 | +21.03% |
| October, 2029 | $0.4059 | $0.4059 | $0.6686 | -5.61% |
| November, 2029 | $0.4191 | $0.365 | $0.5749 | -2.53% |
| December, 2029 | $0.2609 | $0.2067 | $0.4713 | -39.33% |
Estrella Immunopharma Inc Stock (ESLA) Price Forecast for 2030
Estrella Immunopharma Inc Stock (ESLA) is expected to reach an average price of $1.2595 in 2030, with a high forecast of $2.4774 and a low forecast of $0.0417. This signifies an +192.91% surge from the last price of $0.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.2203 | $0.159 | $0.3968 | -48.76% |
| February, 2030 | $0.0771 | $0.0417 | $0.3231 | -82.08% |
| March, 2030 | $1.55 | $0.0632 | $0.4876 | +260.47% |
| April, 2030 | $2.3391 | $2.382 | $2.3636 | +443.98% |
| May, 2030 | $2.1364 | $2.4864 | $2.4628 | +396.84% |
| June, 2030 | $2.5137 | $2.3282 | $2.4237 | +484.59% |
| July, 2030 | $2.4127 | $2.5328 | $2.4774 | +461.10% |
| August, 2030 | $2.4601 | $2.4765 | $2.3347 | +472.12% |
| September, 2030 | $2.3593 | $2.4856 | $2.4156 | +448.66% |
| October, 2030 | $2.2667 | $2.3366 | $2.2059 | +427.13% |
| November, 2030 | $2.3239 | $2.3239 | $2.262 | +440.43% |
| December, 2030 | $2.334 | $2.3057 | $2.2311 | +442.78% |
4.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):